EUVIMEDEUVIMED entdecken
Open Access

GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?

Anna Zucker

Journal of Medical Internet Research · 19.10.2026 · 28 · e113477-e113477

DOI: 10.2196/113477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 19.10.2026. Verfasst von Anna Zucker. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Body Image, Advertising. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GLP-1 medications are incredibly accessible—while this may be a net positive for eligible patients, their widespread marketing may not be. In this News and Perspectives article, JMIR Correspondent Anna Zucker reports on concerns being raised about the potential impact of GLP-1 marketing practices on body image and well-being.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1Body ImageAdvertisingHumans

Stichwörter der Autor:innen

GLP-1advertisingbody imagedigital healtheating disorderglucagon-like peptide-1 receptor agonistmental healthsocial mediatelehealth

Substanzen

Glucagon-Like Peptide 1

Zitieren

APA

Zucker, A. (2026). GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?. Journal of Medical Internet Research, 28, e113477-e113477. https://doi.org/10.2196/113477

Vancouver

Zucker A. GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?. Journal of Medical Internet Research. 2026;28:e113477-e113477. doi:10.2196/113477

BibTeX
@article{Zucker2026,
  author = {Zucker, Anna},
  title = {GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e113477--e113477},
  doi = {10.2196/113477}
}
Kostenlos starten →